Applied DNA Sciences, Inc.: U.S. FDA Lists Applied DNA's Linea COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)
(2) - Early and Cost-Effective Identification of Samples Potentially Containing the B.1.1.7 or Other Variants May Help Reduce Further Spread of Infection - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that the U.S. Food and Drug Administration (FDA) published a safety communication (the "Communication") that identifies the Company's Linea COVID-19 Assay Kit (the "Assay Kit") as one of only two tests marketed under the FDA's Emergency Use Authorization (EUA) that are potentially able to identify ...
Source: finanznachrichten.de